Evaluation of ELISA and dot blots for the serodiagnosis of neurocysticercosis, in children found to have single or multiple enhancing lesions in computerized tomographic scans of the brain

References

• Bedi, S., Prasad, A. & Anand, K. S. (2001). Neurocysticercal serodiagnosis updated. Journal of the Indian Medical Association, 99, 22–25.
   Google Scholar
• Brooks, R. G., Sharma, S. D. & Remington, J. S. (1985). Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. Journal of Clinical Microbiology, 21, 113–116.
   PubMed Web of Science ®Google Scholar
• Corona, T., Pascoe, D., Gonzalez-Barranco, D., Abad, P., Landa, L. & Estanol, B. (1986). Anticysticercosis antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis. Journal of Neurology, Neurosurgery and Psychiatry, 49, 1044–1049.
   Google Scholar
• Das, S., Mahajan, R. C., Ganguly, N. K., Sawhney, I. M. S., Dhawan, V. & Malla, N. (2002). Detection of antigen B of Cysticercus cellulosae in cerebrospinal fluid for the diagnosis of human neurocysticercosis. Tropical Medicine and International Health, 7,53–58.
   PubMed Web of Science ®Google Scholar
• Del Brutto, O. H., Rajshekhar, V., White, A. C. Jr, Tsang, V. C., Nash, T. E., Takayanagui, O. M., Schantz, P. M., Evans, C. A., Flisser, A., Correa, D., Botero, D., Allan, J. C., Sarti, E., Gonzalez, A. E., Gilman, R. H. & Garcia, H. H. (2001). Proposed diagnostic criteria for neurocysticercosis. Neurology, 57, 177–183.
   Google Scholar
• Diwan, A. R., Coker-Vann, M., Brown, M., Subianto, D. B., Yolken, R., Desowitz, R., Escobar, A., Gibbs C. J Jr,. & Gajdusek, D. C. (1982). Enzyme linked immunosorbent assay (ELISA) for the detection of antibody to cysticerci of Taenia solium. American Journal of Tropical Medicine and Hygiene, 31, 364–369.
   Google Scholar
• Espinoza, B., Ruiz Palacios, G., Tovar, A., Sandoval, M. A., Plancarti, A. & Flisser, A (1986). Characterization by ELISA of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis. Journal of Clinical Microbiology, 24, 536–541.
   PubMed Web of Science ®Google Scholar
• Estrada, J. J., Estrada, J. A. & Kuhn, R. (1989). Identification of Taenia solium antigens in cerebrosp-inal fluid and larval antigens from patients with neurocysticercosis. American Journal of Tropical Medicine and Hygiene, 41, 50–55.
   PubMed Web of Science ®Google Scholar
• Galen, R. S. & Gambino, S. R. (1975). Beyond Normality: the Predictive Value and Efficiency of Medical Diagnosis. New York, NY: John Wiley.
   Google Scholar
• Grover, R., Mahajan, R. C. & Malla, N. (2002). Increasing trends of seropositivity to Cysticercus cellulosae antigen in clinically suspected neurocysti-cercosis in children. Indian Journal of Pathology and Microbiology, 45, 411–415.
   Google Scholar
• Idris, M., Heiner, D. C., Miller, B. L., Goldberg, M. A. & Kagan, I. G. (1984). Enzyme linked immunosor-bent assay for diagnosis of cerebral cysticercosis. Journal of Clinical Microbiology, 20, 775–779.
   Google Scholar
• Katti, M. & Chandramukhi, A. (1991). Comparative evaluation of cysticercal antigens and immunoassays in the diagnosis of cysticercosis. Annals of Tropical Medicine and Parasitology, 85, 605–615.
   PubMed Web of Science ®Google Scholar
• Kaur, M., Goyal, R., Ganguly, N. K., Mahajan, R. C. & Malla, N. (1996). Evaluation and characterization of purified antigenic fraction II of Cysticercus cellulosae by ELISA for the diagnosis of neurocysticercosis: before and after treatment. Immunology and Infectious Diseases, 6, 25–29.
   Google Scholar
• Kossoff, E. H. (2003). Neuroimaging in neurocysticer-cosis eMedicine (http://www.emedicine.com/ped/ top ic1573 .htm) .
   Google Scholar
• Larralde, C., Laclette, J. P., Owen, C. S., Madrazo, I., Sandoval, M., Bojalil, R., Sciutto, E., Contreras, L., Arzate, J., Diaz, M. L., Govezensky, T., Montoya, R. M. & Goodsaid, F. (1986). Reliable serology of Taenia solium cysticercosis with antigens from cyst vesicular fluid: ELISA and hemagglutination tests. American Journal of Tropical Medicine and Hygiene, 35, 963–973.
   Google Scholar
• Lowry, O. H., Rosebrough, N. K., Farr, A. L. & Randall, R. J. (1951). Protein measurement with folin phenol reagent. Journal of Biological Chemistry, 193, 265.
   Google Scholar
• Mahajan, R. C. (1982). Geographical distribution of human cysticercosis. In Cysticercosis - Present State of Knowledge and Perspectives, ed. Flisser A. pp. 39-46. New York, NY: Academic Press.
   Google Scholar
• Mahajan, R. C., Sehgal, R., Malla, N. & Ganguly, N. K. (1989). Dot enzyme linked immunosorbent assay(dot-ELISA) for immunodiagnosis of amoebiasis. Indian Journal of Medical Research, 89, 100–104.
   PubMed Web of Science ®Google Scholar
• Malla, N., Kaur, M., Kaur, U., Ganguly, N. K. & Mahajan, R. C. (1992). Evaluation of enzyme-linked immunosorbent assay for the detection of antic-ysticercus antibodies in cerebrospinal fluid from patients with neurocysticercosis. Journal of Hygiene, Epidemiology, Microbiology and Immunology, 36, 181–190.
   PubMedGoogle Scholar
• Pappas, M. G., Hajkowski, R. & Hockmeyer, W. T. (1983). Dot enzyme-linked immunosorbent assay (dot-ELISA): a micro technique for the rapid diagnosis of visceral leishmaniasis. Journal of Immunological Methods, 64, 205–214.
   PubMed Web of Science ®Google Scholar
• Plancarte, A., Fexas, M. & Flisser, A. (1994). Reactivity in ELISA and dot blot of purified GP 24, an immunodominant antigen of Taenia solium for the diagnosis of human neurocysticercosis. International Journal for Parasitology, 24, 733–738.
   Google Scholar
• Proano-Narvaez, J. V., Meza-Lucas, A., Meta-Luiz, O., Garcia-Jeronimo, R. C. & Correa, D. (2002). Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immuno-sorbent assay and electroimmunotransfer blot assay. Journal of Clinical Microbiology, 40, 2115–2118.
   PubMed Web of Science ®Google Scholar
• Rajashekhar, V., Wilson, M. & Schantz, P. M. (1991). Cysticercus immunoblot assay in Indian patients with single enhancing small CT lesions. Journal of Neurology, Neurosurgery and Psychiatry, 54, 561–562.
   Web of Science ®Google Scholar
• Sawhney, I. M. S., Lekhra, O. P., Shashi, J. S., Prabhakar, S. & Chopra, J. S. (1996). Evaluation of epilepsy management in a developing country: a prospective study of 407 patients. Acta Neurologica Scandinavka, 94, 19–23.
   PubMed Web of Science ®Google Scholar
• Singhi, P., Ray, M., Singhi, S. & Khandelwal, N. (2000). Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. Journal of Child Neurology, 15, 207–213.
   PubMed Web of Science ®Google Scholar
• Stamos, J. K., Hahn, Y. S., Chadwick, E. G. & Schantz, P. M. (1996). Neurocysticercosis: report of unusual pediatric cases. Paediatrics, 93, 974–977.
   Google Scholar
• Tellez-Giron, E., Ramos, M. C., Dufour, L., Alvarez, P. & Montante, M. (1987). Detection of Cysticercus cellulosae antigens in cerebrospinal fluid by dot enzyme-linked immunosorbent assay (dot-ELISA) and standard ELISA. American Journal of Tropical Medicine and Hygiene, 37, 169–173.
   Google Scholar
• Voller, A., Bidwell, D. E. & Bartlett, A. (1976). Enzyme immunoassays in diagnostic medicine. Theory and practice. Bulletin of the World Health Organization, 53, 55–65.
   Google Scholar
• White A.C. Jr, (1997). Neurocysticercosis: a major cause of neurological diseases worldwide. Clinical Infectious Diseases, 24, 101–105.
   PubMed Web of Science ®Google Scholar
• Zini, D., Farrell, V. J. R. & Wadee, A. A. (1990). The relationship of antibody levels to the clinical spec-trum of human neurocysticercosis. Journal of Neurology, Neurosurgery and Psychiatry, 53, 656–661.
   Google Scholar